Dr. Bui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2011 - 2014
University of Texas Southwestern Medical SchoolClass of 2011
Certifications & Licensure
CA State Medical License 2012 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective...Ted Kim, Clara Hao, Minggui Pan, Kristen N Ganjoo, Nam Q Bui
Diseases. 2025-03-11 - Histologic and Immunologic Factors Associated with Response to Immune Checkpoint Inhibitors in Advanced Sarcoma.Alex Q Lee, Clara Hao, Minggui Pan, Kristen N Ganjoo, Nam Q Bui
Clinical Cancer Research. 2025-02-17 - Nirogacestat-the pathway to approval of the first treatment for desmoid tumors, a rare disease.Shivaani Kummar, Nam Bui, Wells A Messersmith, Jeanne Whiting, Marlene Portnoy
Therapeutic Advances in Rare Disease. 2025-02-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
